Skip to main content
OpenTrials
Completed

NCT Number: NCT00431158

ARDSnet Protocol vs. Open Lung Approach in ARDS

Many patients with Acute Respiratory Distress Syndrome or ARDS need breathing support that is provided by a machine called a ventilator or respirator. The purpose of this study is to find out if a new method of setting the ventilator for patients with severe ARDS is better than the standard, commonly used way of setting the ventilator.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Massachusetts General Hospital

Boston, Massachusetts, 02114, United States

About this study

The ARDSnet protocol is the current, standard of care for ARDS. Mechanical ventilation is managed using low tidal volumes, relatively high respiratory rates, with oxygenation managed according to PEEP and FIO2 relationships as defined in a table. This study compares the ARDSnet protocol with an open lung approach to mechanical ventilation. The open lung approach uses a technique to recruit collapsed lung areas and then uses the lowest PEEP level that prevents recollapse of recruited lung units. The best PEEP level is determined by a decremental PEEP trial involving a series of pressure measurements taken after the recruitment maneuver. Both the ARDSnet protocol and the open lung approach require low tidal volumes and plateau pressures.

Evidence suggests that using a mechanical ventilation strategy of recruitment maneuvers (to open the collapsed lung) followed by high PEEP (to prevent collapse of the opened lung) with control of transpulmonary pressure through lower plateau pressures would maximize homogeneity within the lung and as such, minimize shearing forces in the lung parenchyma, thus improving ventilation and outcome in mechanically ventilated ARDS patients.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Intubated and mechanically ventilated
  • Diagnosis of ARDS using American-European consensus criteria
  • Enrollment in study < 48 hours since diagnosis of ARDS
  • For 12-36 hrs. (ideally 12-24 hrs) after diagnosis of ARDS, patient must be ventilated as follows: Volume A/C, Tidal volume of 4-8 ml/kg PBW, Plateau pressure ≤ 30 cmH2O, PEEP/FIO2 adjustments using ARDSnet table, Ventilator rate to keep PaCO2 = 35-60 mmHg
  • During the 12-36 hour(ideally 12-24 hr) period, PaO2/FIO2 must remain < 200 mm Hg for an ABG obtained 30 minutes after placement on the following specific ventilator settings: Volume A/C, Tidal volume = 6 ml/kg PBW, Plateau pressure ≤ 30 cmH2O, Inspiratory time ≤ 1 second, PEEP ≥ 10 cmH2O, FIO2 ≥ 0.5, Ventilator rate to keep PaCO2 = 35-60 mmHg
  • No lung recruitment maneuvers or adjunct therapy.
  • Total time on mechanical ventilation < 96 hrs. at time of randomization.

Exclusion criteria

  • Age < 18 years or > 80 years
  • Weight < 35 kg PBW
  • Body mass index > 60
  • Intubated 2° to acute exacerbation of a chronic pulmonary disease
  • Acute brain injury (ICP > 18 mmHg)
  • Immunosuppression 2° to chemo- or radiation therapy
  • Severe cardiac disease(one of the following): New York Heart Association Class 3 or 4, acute coronary syndrome or persistent ventricular tachyarrhythmias
  • Positive laboratory pregnancy test
  • Sickle cell disease
  • Neuromuscular disease
  • High risk of mortality within 3 months from cause other than ARDS, e.g. cancer
  • More than 2 organ failures (not including pulmonary system)
  • Documented lung barotrauma, i.e. chest tube placement other than for fluid drainage
  • Persistent hemodynamic instability or intractable shock
  • Penetrating chest trauma
  • Enrollment in another interventional study

Treatment and study plan

Different Mechanical Ventilation Protocols

Other

OLA Group: Open lung approach protocol and recruitment maneuvers

ARDSnet Group: ARDSnet protocol

Primary outcomes

  1. 60 day mortality

    Time frame: 60 days

Secondary outcomes

  1. ICU mortality

    Time frame: Duration of ICU stay

  2. Hospital mortality

    Time frame: Duration of hospital stay

  3. 28 day mortality

    Time frame: 28 days

  4. 180 day mortality

    Time frame: 180 days

  5. 365 day mortality

    Time frame: 365 days

  6. Ventilator free days

    Time frame: Hospital stay

  7. Length of ICU stay

    Time frame: Duration of ICU stay

  8. Development of extra-pulmonary organ failures

    Time frame: Duration of hospital stay

  9. Duration of hospitalization

    Time frame: Duration of hospital stay

  10. Incidence of barotrauma

    Time frame: Duration of hospital stay

  11. Systemic inflammatory mediator levels

    Time frame: Duration of hospital stay

  12. Lung function 6 months after discharge

    Time frame: 6 months

  13. Lung function 12 months after discharge

    Time frame: 12 months

  14. Need for rescue therapy

    Time frame: Duration of hospital stay

  15. Ventilation associated pneumonia rate

    Time frame: Duration of hospital stay

Sponsors and collaborators

Lead sponsor

Massachusetts General Hospital

Other

Registry information

Official study title

ARDSnet Protocol vs. the Open Lung Approach for the Ventilatory Management of Severe, Established ARDS: A Global Randomized Controlled Trial

Important dates

Study start
2007
Primary completion
2012
Study completion
2013
First posted
Feb 5, 2007
Registry last updated
Sep 18, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.